# Propanc Biopharma, Inc.: filings

PPCB · Nasdaq · CIK 1517681 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/ppcb.md) · [Financials](/companies/ppcb/financials.md) · [Filings](/companies/ppcb/filings.md) · [Insiders](/companies/ppcb/insiders.md)

## Reports and events: 233 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 130, 10-Q 44, CORRESP 37, 424B3 25, S-1/A 24, UPLOAD 24, EFFECT 21, S-1 17, 10-K 15, D 15, PRE 14C 15, DEF 14C 14, 4 9, NT 10-Q 8, POS AM 7, NT 10-K 6, SC 13G 5, 3 4, RW 3, 424B4 2, PRER14C 2, 10-Q/A 1, 3/A 1, 8-A12B 1, 8-A12G 1, 8-K/A 1, CERT 1, PRE 14A 1, RW WD 1, SC 13D 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 17:00 ET | [8-K](/filings/0001493152-26-049298.md) | 3.01 Delisting notice | 0001493152-26-049298 |
| 2026-10-05 | 17:15 ET | [S-1](/filings/0001493152-26-045770.md) | Registration statement | 0001493152-26-045770 |
| 2026-09-25 | 17:08 ET | [10-K](/filings/0001493152-26-044373.md) | Annual report, period 2026-06-30 | 0001493152-26-044373 |
| 2026-07-17 | 17:30 ET | [S-1](/filings/0001493152-26-033807.md) | Registration statement | 0001493152-26-033807 |
| 2026-07-14 | 16:01 ET | [8-K](/filings/0001493152-26-033173.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-033173 |
| 2026-05-14 | 17:30 ET | [10-Q](/filings/0001493152-26-023210.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023210 |
| 2026-04-10 | 17:29 ET | [S-1](/filings/0001493152-26-016228.md) | Registration statement | 0001493152-26-016228 |
| 2026-02-26 | 17:19 ET | [8-K](/filings/0001493152-26-008196.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-008196 |
| 2026-02-19 | 17:28 ET | [S-1/A](/filings/0001493152-26-007492.md) | Registration statement, amended | 0001493152-26-007492 |
| 2026-02-17 | 14:54 ET | [10-Q](/filings/0001493152-26-007052.md) | Quarterly report, period 2025-12-31 | 0001493152-26-007052 |
| 2026-02-02 | 17:29 ET | [S-1](/filings/0001493152-26-004792.md) | Registration statement | 0001493152-26-004792 |
| 2026-01-07 | 17:00 ET | [8-K](/filings/0001493152-26-000834.md) | 3.01 Delisting notice | 0001493152-26-000834 |
| 2025-12-30 | 20:05 ET | [S-1](/filings/0001493152-25-029472.md) | Registration statement | 0001493152-25-029472 |
| 2025-11-14 | 11:59 ET | [10-Q](/filings/0001493152-25-023213.md) | Quarterly report, period 2025-09-30 | 0001493152-25-023213 |
| 2025-11-10 | 17:22 ET | [8-K](/filings/0001493152-25-021567.md) | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-021567 |
| 2025-10-14 | 17:25 ET | [8-K](/filings/0001493152-25-018054.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-018054 |
| 2025-09-29 | 17:29 ET | [10-K](/filings/0001493152-25-016069.md) | Annual report, period 2025-06-30 | 0001493152-25-016069 |
| 2025-08-19 | 17:24 ET | [8-K](/filings/0001641172-25-024872.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-024872 |
| 2025-08-13 | 17:13 ET | [8-K](/filings/0001641172-25-023580.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-023580 |
| 2025-07-30 | 16:44 ET | [8-K](/filings/0001641172-25-021560.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-021560 |
| 2025-07-28 | 17:12 ET | [S-1/A](/filings/0001641172-25-021182.md) | Registration statement, amended | 0001641172-25-021182 |
| 2025-07-22 | 16:14 ET | [8-K](/filings/0001641172-25-020574.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-020574 |
| 2025-06-27 | 18:16 ET | [8-K](/filings/0001641172-25-016719.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-016719 |
| 2025-06-18 | 17:24 ET | [8-K](/filings/0001641172-25-015642.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-015642 |
| 2025-06-02 | 17:29 ET | [8-K](/filings/0001641172-25-013285.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-013285 |
| 2025-05-30 | 15:39 ET | [S-1/A](/filings/0001641172-25-013004.md) | Registration statement, amended | 0001641172-25-013004 |
| 2025-05-15 | 15:40 ET | [10-Q](/filings/0001641172-25-010798.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010798 |
| 2025-05-08 | 21:56 ET | [8-K](/filings/0001641172-25-009121.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-009121 |
| 2025-04-25 | 14:45 ET | [S-1/A](/filings/0001641172-25-006154.md) | Registration statement, amended | 0001641172-25-006154 |
| 2025-04-21 | 13:50 ET | [8-K](/filings/0001641172-25-005511.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-005511 |
| 2025-04-08 | 17:31 ET | [S-1/A](/filings/0001641172-25-003278.md) | Registration statement, amended | 0001641172-25-003278 |
| 2025-04-02 | 17:26 ET | [S-1/A](/filings/0001641172-25-002435.md) | Registration statement, amended | 0001641172-25-002435 |
| 2025-03-31 | 06:19 ET | [S-1/A](/filings/0001641172-25-001355.md) | Registration statement, amended | 0001641172-25-001355 |
| 2025-03-18 | 13:36 ET | [8-K](/filings/0001493152-25-010716.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-010716 |
| 2025-02-14 | 13:19 ET | [10-Q](/filings/0001493152-25-006697.md) | Quarterly report, period 2024-12-31 | 0001493152-25-006697 |
| 2025-02-12 | 16:10 ET | [8-K](/filings/0001493152-25-006126.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-006126 |
| 2024-12-20 | 17:30 ET | [8-K](/filings/0001493152-24-051125.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-051125 |
| 2024-12-06 | 16:57 ET | [8-K](/filings/0001493152-24-049110.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-049110 |
| 2024-11-14 | 14:14 ET | [10-Q](/filings/0001493152-24-045664.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045664 |
| 2024-10-30 | 06:46 ET | [S-1](/filings/0001493152-24-042965.md) | Registration statement | 0001493152-24-042965 |
| 2024-09-30 | 16:53 ET | [10-K](/filings/0001493152-24-038815.md) | Annual report, period 2024-06-30 | 0001493152-24-038815 |
| 2024-09-27 | 12:37 ET | [8-K](/filings/0001493152-24-038462.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-038462 |
| 2024-08-30 | 17:25 ET | [8-K](/filings/0001493152-24-034647.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-034647 |
| 2024-08-15 | 20:31 ET | [8-K](/filings/0001493152-24-032469.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-032469 |
| 2024-08-07 | 15:37 ET | [8-K](/filings/0001493152-24-030540.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-030540 |
| 2024-07-02 | 13:29 ET | [8-K](/filings/0001493152-24-025929.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-025929 |
| 2024-06-21 | 08:59 ET | [8-K](/filings/0001493152-24-024632.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-024632 |
| 2024-06-13 | 06:10 ET | [8-K/A](/filings/0001493152-24-023626.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-023626 |
| 2024-06-12 | 06:01 ET | [8-K](/filings/0001493152-24-023525.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-023525 |
| 2024-06-05 | 06:05 ET | [8-K](/filings/0001493152-24-022624.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-022624 |

Page 1 of 5. [Older](/companies/ppcb/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:01 ET. No prices; not investment advice.